Hangzhou, China · Founded 2020 · In IPO Registration
Developer of an artificial intelligence platform designed to optimize pharmaceutical formulation processes. METis TechBio is based in Hangzhou, China and was founded in 2020. It has raised $315 million.
Last price · $/share
—
Implied valuation
—
Total raised
$314.7M
Last round
—
Team — not yet on record
No current team members for METis TechBio are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of METis TechBio with a free account
·The complete investor list: 19 names
·Watch METis TechBio: the Monday email on marks, rounds and moves
